Xlife Sciences AG (XSWX:XLS) ROE % Adjusted to Book Value : 15.94% (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Xlife Sciences AG ROE % Adjusted to Book Value?

Xlife Sciences AG's ROE % for the quarter that ended in Dec. 2023 was 16.58%. Xlife Sciences AG's PB Ratio for the quarter that ended in Dec. 2023 was 1.04. Xlife Sciences AG's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was 15.94%.

Xlife Sciences AG ROE % Adjusted to Book Value Historical Data

The historical data trend for Xlife Sciences AG's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xlife Sciences AG ROE % Adjusted to Book Value Chart

Xlife Sciences AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

9.57

5.68

Xlife Sciences AG Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial					-	-10.01	29.49	-5.65	15.94

Competitive Comparison of Xlife Sciences AG's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Xlife Sciences AG's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Xlife Sciences AG's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Xlife Sciences AG's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Xlife Sciences AG's ROE % Adjusted to Book Value falls into.

Xlife Sciences AG ROE % Adjusted to Book Value Calculation

Xlife Sciences AG's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	5.91%	/	1.04
	=	5.68%

Xlife Sciences AG's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	16.58%	/	1.04
	=	15.94%

Xlife Sciences AG ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Xlife Sciences AG's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Xlife Sciences AG (XSWX:XLS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xlife Sciences AG (XSWX:XLS) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

XLSz:UK

Address

Talacker 35, Zürich, CHE, 8001

Website

https://www.xlifesciences.ch

Xlife Sciences AG is a Swiss company with a focus on performance technologies in life sciences. The company allows its investors a very early and direct Entry into the further development of innovative and future-oriented technologies.

Xlife Sciences AG (XSWX:XLS) Headlines

No Headlines